Buy Or Sell Opportunity • Jun 11
Now 93% overvalued after recent price rise Over the last 90 days, the stock has risen 5.0% to €0.011. The fair value is estimated to be €0.0054, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 100% over the last 3 years. Earnings per share has grown by 99%. Buy Or Sell Opportunity • May 27
Now 23% undervalued Over the last 90 days, the stock has risen 11% to €0.011. The fair value is estimated to be €0.014, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 77% over the last 3 years. Meanwhile, the company has become profitable. Board Change • May 20
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 4 non-independent directors. Director Charlie Park was the last director to join the board, commencing their role in 2025. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. Announcement • Nov 22
Blackhawk Growth Corp. Announces Board Changes Blackhawk Growth Corp. announced Appointment of Kyung-Hoon Park as New Director, effective 21 November 2025. Kyung-Hoon (Charlie) Park is an entrepreneur with over ten years of experience operating multiple companies in technology and platform-driven industries. He has served as both CEO and CTO, leading service architecture design, technical development, digital transformation, and operational optimization. His expertise spans startup discovery, business model validation, scalable growth strategies, and strategic partnerships including fundraising support. With successful exit experience from a technology-driven company, he brings strong capabilities in value creation and tech-focused M&A execution. He contributes to the growth and global expansion of technology-oriented organizations through execution-driven leadership and practical problem-solving skills. Anthony Haberfield has resigned as director. Announcement • Mar 25
Blackhawk Growth Corp. announced that it expects to receive CAD 0.504 million in funding Blackhawk Growth Corp. announced a non-brokered private placement that it will issue up to 28,000,000 shares at an issue price of CAD 0.018 per share for the gross proceeds of up to CAD 504,000 on March 24, 2025. All securities issued under the Offering are subject to a four-month and one day statutory hold period. Finder's fees may be payable to qualified individuals pursuant to which the Finder may receive a finder fee equal to up to 8% of the gross proceeds received by the Company from purchasers under the Offering who were introduced to the Company. The Company is also pleased to announce that Shape Capital has agreed to convert CAD 500,000 of the outstanding loan at CAD 0.05 by issuing 10,000,000 shares. The conversion reduces the debt by 22% and further strengthen Blackhawk’s balance sheet. Announcement • Apr 17
Blackhawk Growth Corp Advances Human Clinical Trials in Asthmatic AI Technology Blackhawk Growth Corp. provided an update on Asthmatic AI. The company reported that Asthmatic AI, a company has completed 50 participants in human clinical trials and is now working on the next 250 participants as it develops its Asthma attack prediction technology for use in the clinical management of Asthma. Uniquely, Asthmatic AI uses wearable devices and a mobile application over smartphone to collect data, assess the risk of an asthma attack occurring and then intervene before it occurs. The AI models cross reference an individual's biophysical information such as heart rate, respiratory rate, heart rate variability, blood pressure, cough and wheeze rates with public health data, pollen and location data to interpret an individual's risk of an asthma attack. With over 1,000 asthma deaths reported daily according to the World Health Organization and the burden on social, employment, education and family, Asthmatic AI proposes a novel solution for the management of this serious health condition. Hardenbrook Group works with world class research-intensive organizations to identify valuable intellectual property to invest and commercialize. This provides Blackhawk with the ability to incubate and either M&A or spin out these new innovative companies as a new listing on stock exchanges globally. Hardenbrook has merged its portfolio of Health tech AI focused companies including Asthmatic AI, Mood AI and Autism AI with a significant pipeline of health-tech AI related projects for launch in the near horizon. Life AI Corp. will be the holding company for all health tech AI companies and is also preparing to be spun out and publicly listed. Announcement • Apr 03
Blackhawk Growth Corp., Annual General Meeting, May 17, 2024 Blackhawk Growth Corp., Annual General Meeting, May 17, 2024. New Risk • Feb 25
New major risk - Financial position The company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -CA$283k This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CA$283k free cash flow). Share price has been highly volatile over the past 3 months (104% average daily change). Negative equity (-CA$2.4m). Earnings have declined by 56% per year over the past 5 years. Revenue is less than US$1m. Market cap is less than US$10m (€1.07m market cap, or US$1.16m). New Risk • Nov 03
New major risk - Negative shareholders equity The company has negative equity. Total equity: -CA$823k This is considered a major risk. Being in negative equity means that the company's liabilities exceed its assets, meaning it owes more to creditors than it has in owned assets. While this doesn't mean the company is about to collapse, in the long-term, this is unsustainable. The company may have issues meeting financial obligations, is at risk of becoming insolvent and may have difficulty raising capital, especially more debt, if needed. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (81% average daily change). Negative equity (-CA$823k). Earnings have declined by 56% per year over the past 5 years. Revenue is less than US$1m. Market cap is less than US$10m (€534.5k market cap, or US$567.7k). Announcement • May 31
Blackhawk Growth Corp. (CNSX:BLR) entered into a share purchase agreement to acquire Hardenbrook Group Pty Ltd for AUD 4.6 million. Blackhawk Growth Corp. (CNSX:BLR) entered into a share purchase agreement to acquire Hardenbrook Group Pty Ltd for AUD 4.6 million on May 29, 2023. Pursuant to the terms of a share purchase agreement, dated May 29, 2023, the Company to acquire all of the outstanding share capital of Hardenbrook Group Pty Ltd to issue 70,000,000 common shares to the existing shareholders of Hardenbrook at a deemed price of AUD 0.05 per share and 15,000,000 Warrants with an exercise price of AUD 0.10. No finders’ fees or commissions were paid in connection with closing of the acquisition. The acquisition of Hardenbrook is subject to shareholder approval. Further updates will be provided to shareholders. As a result the issued share capital will increase from 77,995,593 Shares to 147,995,593 Shares. Shareholder approval and CSE approval is required and a valuation report will be obtained. Board Change • May 10
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. Chairman Justin Hanka was the last director to join the board, commencing their role in 2022. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. 
